Latest Articles

In a study published in Metabolic Engineering, bovine cells were engineered to endogenously produce phytoene, lycopene and β-carotene. We recently had the pleasure of speaking to Andrew Stout, lead author of the study, to learn how these cells were created and explore some of the benefits of engineering in the abilities to produce additional nutrients.

A research team from The Walter and Eliza Hall Institute has adopted a single-cell, multi-omics approach to explore this question, focusing particularly on T and B lymphocyte formation. They discovered a new stage in lymphocyte development, information which the researchers say could "enrich future studies of the immune system". We wanted to know more.

Researchers must consider a number of factors for in vitro experiments. Selecting the most appropriate cell line or primary culture for the project at hand is only the first step. Researchers must then be vigilant to prevent contaminating the culture, from the initial moments it is plated and all throughout consecutive passages.

Large-scale testing and contact tracing are central to efforts to control the pandemic. This relies on diagnostic tests that can rapidly, accurately and reliably detect SARS-CoV-2.

In this article, we discuss the current techniques that are available for oligonucleotide analysis.

To learn more about the PANDIS model, its aims, and how it can be used to help diagnose and treat patients suffering from a range of conditions spanning from cancers to “mystery chronic diseases”, Technology Networks spoke with PANDIS’s founders, Professor Gilles Guillemin and Catherine Stace.

How do we use the information obtained from metabolomics approaches to move towards personalized nutrition? That's the focus of this interview with Professor Lorraine Brennan, Conway Fellow and principal investigator at the University College Dublin Institute of Food and Health.

An ambitious new research project powered by hitherto inaccessible techniques is investigating whether a crowded cellular environment might have a role to play in the origin of neurodegeneration.

CRISPR has been a challenge to implement due to a range of limitations. As a community, we must set aside our excitement to take a clear-eyed look at the hurdles that need to be overcome before CRISPR can achieve the potential we believe it has.

In a recent preprint study, a team of researchers from Gladstone Institutes discovered new insights into how SARS-CoV-2 causes heart damage. To learn more about the findings and their implications for the monitoring and treatment of COVID-19 patients, we spoke to Bruce Conklin, MD, senior investigator at Gladstone Institutes.